VanEck Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135M | Buy |
|
|||||
|
2025
Q1 | $147M | Buy |
|
|||||
|
2024
Q4 | $163M | Buy |
|
|||||
|
2024
Q3 | $18.1M | Sell |
|
|||||
|
2024
Q2 | $214M | Sell |
|
|||||
|
2024
Q1 | $375M | Buy |
|
|||||
|
2023
Q4 | $368M | Buy |
|
|||||
|
2023
Q3 | $306M | Buy |
|
|||||
|
2023
Q2 | $272M | Buy |
|
|||||
|
2023
Q1 | $225M | Buy |
|
|||||
|
2022
Q4 | $218M | Sell |
|
|||||
|
2022
Q3 | $245M | Sell |
|
|||||
|
2022
Q2 | $194M | Buy |
|
|||||
|
2022
Q1 | $198M | Buy |
|
|||||
|
2021
Q4 | $192M | Buy |
|
|||||
|
2021
Q3 | $181M | Buy |
|
|||||
|
2021
Q2 | $207M | Sell |
|
|||||
|
2021
Q1 | $175M | Buy |
|
|||||
|
2020
Q4 | $127M | Buy |
|
|||||
|
2020
Q3 | $124M | Buy |
|
|||||
|
2020
Q2 | $103M | Buy |
|
|||||
|
2020
Q1 | $110M | Sell |
|
|||||
|
2019
Q4 | $121M | Buy |
|
|||||
|
2019
Q3 | $84.3M | Buy |
|
|||||
|
2019
Q2 | $72.5M | Buy |
|
|||||
|
2019
Q1 | $59M | Buy |
|
|||||
|
2018
Q4 | $64.9M | Buy |
|
|||||
|
2018
Q3 | $72.8M | Sell |
|
|||||
|
2018
Q2 | $62.1M | Buy |
|
|||||
|
2018
Q1 | $55.9M | Sell |
|
|||||
|
2017
Q4 | $72.6M | Sell |
|
|||||
|
2017
Q3 | $73.7M | Sell |
|
|||||
|
2017
Q2 | $69.7M | Buy |
|
|||||
|
2017
Q1 | $68M | Buy |
|
|||||
|
2016
Q4 | $60.3M | Buy |
|
|||||
|
2016
Q3 | $62.4M | Sell |
|
|||||
|
2016
Q2 | $50M | Sell |
|
|||||
|
2016
Q1 | $64M | Sell |
|
|||||
|
2015
Q4 | $79.6M | Buy |
|
|||||
|
2015
Q3 | $48.6M | Buy |
|
|||||
|
2015
Q2 | $63.5M | Sell |
|
|||||
|
2015
Q1 | $67.3M | Buy |
|
|||||
|
2014
Q4 | $45.8M | Sell |
|
|||||
|
2014
Q3 | $45.9M | Sell |
|
|||||
|
2014
Q2 | $48.1M | Sell |
|
|||||
|
2014
Q1 | $51.4M | Buy |
|
|||||
|
2013
Q4 | $40.7M | Buy |
|
|||||
|
2013
Q3 | $33M | Buy |
|
|||||
|
2013
Q2 | $20.8M | Buy |
|